FDA Recall United States TerminatedTerminated: March 22, 2024Historical recordClass II
Kawasho Foods USA, Inc
- Product
- Geisha Medium Shrimp; WT 4OZ(113g)
- Reason
- Canned shrimp may be under-processed
- Published
- May 31, 2023
- Distribution
- Nationwide
Data Explorer
Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.
Recall totals
All FDA and USDA recalls in Public Health Trace, June 2012 to October 2026.
37,324
Total recall recordsAll FDA and USDA recalls in Public Health Trace9,859
Class I recallsReasonable probability of serious health consequences24,440
Class II recallsTemporary or medically reversible health consequences2,900
Class III recallsNot likely to cause adverse health consequencesQuick insights
A snapshot of the most notable patterns across all recorded FDA and USDA recalls.
Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap.
53 recalls
Most common hazardLack of Assurance of Sterility
2,095 recalls
Newest recallhttps://www.fsis.usda.gov/recalls-alerts/kayem-foods-inc--recalls-meat-and-poultry-products-due-possible-temperature-abusePublished October 17, 2026
Download matching recalls as CSV
CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.
Filters
Metric
View
A chart of recalls grouped by month.
Download CSVSummary (Year to date)
- 1,739 recalls have been announced year to date.
- Sep 2026 was 15% higher than the previous complete period (Aug 2026: 182).
- The highest complete period was Jun 2026 (300).
- Oct 2026 is incomplete and not included in the figures above.
- Complete data
- Incomplete
A bar chart of the total number of recalls in this dataset by recall class.
| Class | Recalls |
|---|---|
| Class II | 24,440 |
| Class I | 9,859 |
| Class III | 2,900 |
| Not Yet Classified | 2 |
| Class | Recalls |
|---|---|
| Class II | 24,440 |
| Class I | 9,859 |
| Class III | 2,900 |
| Not Yet Classified | 2 |
FDA Recall United States TerminatedTerminated: August 8, 2023Historical recordClass I
Lancaster Foods LLC
- Product
- LANCASTER SPINACH, 10 OZ, UPC:8-13055-01145-3. Packaged in s…
- Reason
- Possible contamination with listeria monocytogenes
- Published
- May 31, 2023
- Distribution
- Distributors and retailers in MA, MD, PA…
FDA Recall United States TerminatedTerminated: August 8, 2023Historical recordClass I
Lancaster Foods LLC
- Product
- ROBINSON FRESH COLLARD GREENS, 16 OZ, UPC:0-95829-60006-7. P…
- Reason
- Possible contamination with listeria monocytogenes
- Published
- May 31, 2023
- Distribution
- Distributors and retailers in MA, MD, PA…
FDA Recall United States TerminatedTerminated: August 8, 2023Historical recordClass I
Lancaster Foods LLC
- Product
- GIANT CURLY LEAF SPINACH, 12 /8 OZ, UPC: 6-88267-09813-0. Pa…
- Reason
- Possible contamination with listeria monocytogenes
- Published
- May 31, 2023
- Distribution
- Distributors and retailers in MA, MD, PA…
FDA Recall United States TerminatedTerminated: August 8, 2023Historical recordClass I
Lancaster Foods LLC
- Product
- ROBINSON FRESH KALE GREENS, NET WT 16 OZ, UPC:0-95829-60015.…
- Reason
- Possible contamination with Listeria monocytogenes
- Published
- May 31, 2023
- Distribution
- Distributors and retailers in MA, MD, PA…
FDA Recall TerminatedTerminated: April 5, 2024Historical recordClass II
Piperacillin and Tazobactam for Injection, UPS, 3.375 grams per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-079-02
- Reason
- Lack of Assurance of Sterility
- Published
- May 24, 2023
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: April 5, 2024Historical recordClass II
Piperacillin and Tazobactam for Injection, USP, 4.5 grams per vial, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017, NDC 66794-218-41
- Reason
- Lack of Assurance of Sterility
- Published
- May 24, 2023
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: April 5, 2024Historical recordClass II
Piperacillin and Tazobactam for Injection, USP 3.375 grams per vial, Rx only, Mfd for Meitheal Pharmaceuticals Chicago, IL 60631, NDC 71288-003-31
- Reason
- Lack of Assurance of Sterility
- Published
- May 24, 2023
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: April 5, 2024Historical recordClass II
Piperacillin and Tazobactam for Injection, USP, 2.25 grams per vial, Rx only, Mfd for Meitheal Pharmaceuticals Chicago, IL 60631, NDC 71288-002-31
- Reason
- Lack of Assurance of Sterility
- Published
- May 24, 2023
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: April 5, 2024Historical recordClass II
Piperacillin and Tazobactam for Injection, USP, 4.5 grams per vial, Rx only, Manufactured for: Civica Inc. Lehi Utah 84043, NDC 72572-577-10
- Reason
- Lack of Assurance of Sterility
- Published
- May 24, 2023
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: April 5, 2024Historical recordClass II
Piperacillin and Tazobactam for Injection, USP, 3.375 grams per vial, Rx only, Manufactured for: Civica Inc. Lehi Utah 84043, NDC 72572-576-10
- Reason
- Lack of Assurance of Sterility
- Published
- May 24, 2023
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: April 5, 2024Historical recordClass II
Ceftriaxone for Injection, USP, 2 grams per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-097-02
- Reason
- Lack of Assurance of Sterility
- Published
- May 24, 2023
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: April 5, 2024Historical recordClass II
Ceftriaxone for Injection, USP, 1 grams per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-096-02
- Reason
- Lack of Assurance of Sterility
- Published
- May 24, 2023
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: April 5, 2024Historical recordClass II
Ceftriaxone for Injection, USP 500 mg per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-095-02
- Reason
- Lack of Assurance of Sterility
- Published
- May 24, 2023
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: April 5, 2024Historical recordClass II
Ceftriaxone for Injection, USP 250 mg per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-094-02
- Reason
- Lack of Assurance of Sterility
- Published
- May 24, 2023
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: April 5, 2024Historical recordClass II
Ceftriaxone for Injection, USP 10 grams per Pharmacy Bulk Package, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017, NDC 66794-215-15
- Reason
- Lack of Assurance of Sterility
- Published
- May 24, 2023
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: April 5, 2024Historical recordClass II
Ceftriaxone for Injection, USP 2 grams per vial, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017, NDC 66794-214-42
- Reason
- Lack of Assurance of Sterility
- Published
- May 24, 2023
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: April 5, 2024Historical recordClass II
Ceftriaxone for Injection, USP 250 mg per vial, Rx only, Mfg. for: Piramal Critical Care, Bethlehem, PA 18017, NDC 66794-211-42
- Reason
- Lack of Assurance of Sterility
- Published
- May 24, 2023
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: April 5, 2024Historical recordClass II
Cefepime for Injection, USP 1 gram per vial, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-089-02
- Reason
- Lack of Assurance of Sterility
- Published
- May 24, 2023
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: April 5, 2024Historical recordClass II
Cefepime for Injection, USP 2 grams per vial, Rx only, Mfg. for: Piramal Critical Care Bethlehem, PA 18017 USA, NDC 66794-210-41
- Reason
- Lack of Assurance of Sterility
- Published
- May 24, 2023
- Distribution
- Nationwide
Data last updated:
Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.
